Back to Archived Journals » Core Evidence » Volume 9

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]

Total article views   HTML views PDF downloads Totals
8,524 Dovepress* 8,393+ 886 9,279
PubMed Central* 131 62 193
Totals 8,524 948 9,472
*Since 16 May 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar